Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaladhar B Reddy

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cells|May 13, 2026
A Novel Mechanism of STAT3 Activation by Oncogenic SignalingMagesh Muthu, Jaganathan Venkatesh, Kaladhar B Reddy, et al.
Molecular Cancer Therapeutics|January 22, 2011
Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cellsLiping Xu, Shuping Yin, Sanjeev Banerjee, et al.
International Journal of Oncology|June 21, 2011
Cisplatin and TRAIL enhance breast cancer stem cell deathShuping Yin, Liping Xu, Sudeshna Bandyopadhyay, et al.
Molecular Endocrinology (Baltimore, Md.)|February 4, 2006
Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifenSelina Glaros, Natasha Atanaskova, Changqing Zhao, et al.
Plos One|August 18, 2017
Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cellsShuping Yin, Vino T Cheryan, Liping Xu, et al.
Oncogene|May 31, 2002
MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistanceNatasha Atanaskova, Venkateshwar G Keshamouni, Joseph S Krueger, et al.
BMC Cancer|July 25, 2015
Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4Aamir Ahmad, Kevin R Ginnebaugh, Shuping Yin, et al.
Molecular Cancer Therapeutics|March 1, 2013
Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancerShuping Yin, Liping Xu, R Daniel Bonfil, et al.
Oncogene|March 1, 2005
Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cellsSanaa M Nabha, Selina Glaros, Meng Hong, et al.
Oncogene|February 26, 2004
Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activitiesLulu Farhana, Marcia I Dawson, Ying Huang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cells|May 13, 2026
A Novel Mechanism of STAT3 Activation by Oncogenic SignalingMagesh Muthu, Jaganathan Venkatesh, Kaladhar B Reddy, et al.
Molecular Cancer Therapeutics|January 22, 2011
Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cellsLiping Xu, Shuping Yin, Sanjeev Banerjee, et al.
International Journal of Oncology|June 21, 2011
Cisplatin and TRAIL enhance breast cancer stem cell deathShuping Yin, Liping Xu, Sudeshna Bandyopadhyay, et al.
Molecular Endocrinology (Baltimore, Md.)|February 4, 2006
Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifenSelina Glaros, Natasha Atanaskova, Changqing Zhao, et al.
Plos One|August 18, 2017
Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cellsShuping Yin, Vino T Cheryan, Liping Xu, et al.
Oncogene|May 31, 2002
MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistanceNatasha Atanaskova, Venkateshwar G Keshamouni, Joseph S Krueger, et al.
BMC Cancer|July 25, 2015
Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4Aamir Ahmad, Kevin R Ginnebaugh, Shuping Yin, et al.
Molecular Cancer Therapeutics|March 1, 2013
Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancerShuping Yin, Liping Xu, R Daniel Bonfil, et al.
Oncogene|March 1, 2005
Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cellsSanaa M Nabha, Selina Glaros, Meng Hong, et al.
Oncogene|February 26, 2004
Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activitiesLulu Farhana, Marcia I Dawson, Ying Huang, et al.
Pageof 3